世界のポリペプチド薬市場2017

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR70301815)
◆英語タイトル:Global Polypeptide Drug Sales Market Report 2017
◆発行会社/調査会社:QYResearch
◆商品コード:QYR70301815
◆発行日:2017年1月30日
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆ページ数:121
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥872,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のポリペプチド薬市場2017]についてメールでお問い合わせはこちら
当調査レポートでは、世界のポリペプチド薬市場2017について調査・分析し、ポリペプチド薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、主要地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、コスト分析、価格データ、企業情報、ポリペプチド薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・ポリペプチド薬市場概要
・ポリペプチド薬のメーカー別販売量・メーカー別シェア
・ポリペプチド薬の世界市場:種類別販売量・市場シェア
・ポリペプチド薬の世界市場:用途別販売量・市場シェア
・ポリペプチド薬の世界市場:地域別販売量・市場シェア
・ポリペプチド薬の米国市場規模
・ポリペプチド薬の中国市場規模
・ポリペプチド薬の欧州市場規模
・ポリペプチド薬の日本市場規模
・ポリペプチド薬の東南アジア市場規模
・ポリペプチド薬のインド市場規模
・ポリペプチド薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・ポリペプチド薬のコスト分析・価格動向
・ポリペプチド薬の産業チェーン(サプライチェーン分析)
・ポリペプチド薬のマーケティング戦略・販売チャネル、流通業者
・ポリペプチド薬市場への影響要因分析
・ポリペプチド薬の世界市場予測
・ポリペプチド薬の米国市場予測
・ポリペプチド薬の中国市場予測
・ポリペプチド薬の欧州市場予測
・ポリペプチド薬の日本市場予測
・ポリペプチド薬の東南アジア市場予測
・ポリペプチド薬のインド市場予測
・ポリペプチド薬の種類別世界市場予測
・ポリペプチド薬の用途別世界市場予測
...
*** レポート概要(サマリー)***

Notes:Sales, means the sales volume of Polypeptide Drug
Revenue, means the sales value of Polypeptide Drug

This report studies sales (consumption) of Polypeptide Drug in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Polypeptide Drug in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Polypeptide Drug in each application, can be divided into
Application 1
Application 2

*** レポート目次(コンテンツ)***

Table of Contents

Global Polypeptide Drug Sales Market Report 2017
1 Polypeptide Drug Overview
1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Polypeptide Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 Polypeptide Drug Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Polypeptide Drug (2012-2022)
1.5.1 Global Polypeptide Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Polypeptide Drug Revenue and Growth Rate (2012-2022)

2 Global Polypeptide Drug Competition by Manufacturers, Type and Application
2.1 Global Polypeptide Drug Market Competition by Manufacturers
2.1.1 Global Polypeptide Drug Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Polypeptide Drug Revenue and Share by Manufacturers (2012-2017)
2.2 Global Polypeptide Drug (Volume and Value) by Type
2.2.1 Global Polypeptide Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Polypeptide Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Polypeptide Drug (Volume and Value) by Regions
2.3.1 Global Polypeptide Drug Sales and Market Share by Regions (2012-2017)
2.3.2 Global Polypeptide Drug Revenue and Market Share by Regions (2012-2017)
2.4 Global Polypeptide Drug (Volume) by Application

3 United States Polypeptide Drug (Volume, Value and Sales Price)
3.1 United States Polypeptide Drug Sales and Value (2012-2017)
3.1.1 United States Polypeptide Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Polypeptide Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Polypeptide Drug Sales Price Trend (2012-2017)
3.2 United States Polypeptide Drug Sales and Market Share by Manufacturers
3.3 United States Polypeptide Drug Sales and Market Share by Type
3.4 United States Polypeptide Drug Sales and Market Share by Application

4 China Polypeptide Drug (Volume, Value and Sales Price)
4.1 China Polypeptide Drug Sales and Value (2012-2017)
4.1.1 China Polypeptide Drug Sales and Growth Rate (2012-2017)
4.1.2 China Polypeptide Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Polypeptide Drug Sales Price Trend (2012-2017)
4.2 China Polypeptide Drug Sales and Market Share by Manufacturers
4.3 China Polypeptide Drug Sales and Market Share by Type
4.4 China Polypeptide Drug Sales and Market Share by Application

5 Europe Polypeptide Drug (Volume, Value and Sales Price)
5.1 Europe Polypeptide Drug Sales and Value (2012-2017)
5.1.1 Europe Polypeptide Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Polypeptide Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Polypeptide Drug Sales Price Trend (2012-2017)
5.2 Europe Polypeptide Drug Sales and Market Share by Manufacturers
5.3 Europe Polypeptide Drug Sales and Market Share by Type
5.4 Europe Polypeptide Drug Sales and Market Share by Application

6 Japan Polypeptide Drug (Volume, Value and Sales Price)
6.1 Japan Polypeptide Drug Sales and Value (2012-2017)
6.1.1 Japan Polypeptide Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Polypeptide Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Polypeptide Drug Sales Price Trend (2012-2017)
6.2 Japan Polypeptide Drug Sales and Market Share by Manufacturers
6.3 Japan Polypeptide Drug Sales and Market Share by Type
6.4 Japan Polypeptide Drug Sales and Market Share by Application
7 Southeast Asia Polypeptide Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Polypeptide Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Polypeptide Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Polypeptide Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Polypeptide Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Polypeptide Drug Sales and Market Share by Manufacturers
7.3 Southeast Asia Polypeptide Drug Sales and Market Share by Type
7.4 Southeast Asia Polypeptide Drug Sales and Market Share by Application
8 India Polypeptide Drug (Volume, Value and Sales Price)
8.1 India Polypeptide Drug Sales and Value (2012-2017)
8.1.1 India Polypeptide Drug Sales and Growth Rate (2012-2017)
8.1.2 India Polypeptide Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Polypeptide Drug Sales Price Trend (2012-2017)
8.2 India Polypeptide Drug Sales and Market Share by Manufacturers
8.3 India Polypeptide Drug Sales and Market Share by Type
8.4 India Polypeptide Drug Sales and Market Share by Application

9 Global Polypeptide Drug Manufacturers Analysis
9.1 Novartis
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Polypeptide Drug Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Merck Serono
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Polypeptide Drug Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Ferring Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Polypeptide Drug Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Ipsen PHarma Biotech
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Polypeptide Drug Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Lilly
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Polypeptide Drug Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Asahi Kasei
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Polypeptide Drug Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 AstraZeneca
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Polypeptide Drug Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 SciClone Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Polypeptide Drug Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Takeda
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Polypeptide Drug Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview

10 Polypeptide Drug Maufacturing Cost Analysis
10.1 Polypeptide Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Polypeptide Drug
10.3 Manufacturing Process Analysis of Polypeptide Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Polypeptide Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Polypeptide Drug Market Forecast (2017-2022)
14.1 Global Polypeptide Drug Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Polypeptide Drug Price and Trend Forecast (2017-2022)
14.2 Global Polypeptide Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Polypeptide Drug Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Polypeptide Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Polypeptide Drug
Table Classification of Polypeptide Drug
Figure Global Sales Market Share of Polypeptide Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Polypeptide Drug
Figure Global Sales Market Share of Polypeptide Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure China Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Japan Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure India Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Global Polypeptide Drug Sales and Growth Rate (2012-2022)
Figure Global Polypeptide Drug Revenue and Growth Rate (2012-2022)
Table Global Polypeptide Drug Sales of Key Manufacturers (2012-2017)
Table Global Polypeptide Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Polypeptide Drug Sales Share by Manufacturers
Figure 2016 Polypeptide Drug Sales Share by Manufacturers
Table Global Polypeptide Drug Revenue by Manufacturers (2012-2017)
Table Global Polypeptide Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Polypeptide Drug Revenue Share by Manufacturers
Table 2016 Global Polypeptide Drug Revenue Share by Manufacturers
Table Global Polypeptide Drug Sales and Market Share by Type (2012-2017)
Table Global Polypeptide Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Type (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Type (2012-2017)
Table Global Polypeptide Drug Revenue and Market Share by Type (2012-2017)
Table Global Polypeptide Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Type (2012-2017)
Figure Global Polypeptide Drug Revenue Growth Rate by Type (2012-2017)
Table Global Polypeptide Drug Sales and Market Share by Regions (2012-2017)
Table Global Polypeptide Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Regions (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Regions (2012-2017)
Table Global Polypeptide Drug Revenue and Market Share by Regions (2012-2017)
Table Global Polypeptide Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Regions (2012-2017)
Figure Global Polypeptide Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Polypeptide Drug Sales and Market Share by Application (2012-2017)
Table Global Polypeptide Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Application (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Application (2012-2017)
Figure United States Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure United States Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure United States Polypeptide Drug Sales Price Trend (2012-2017)
Table United States Polypeptide Drug Sales by Manufacturers (2012-2017)
Table United States Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table United States Polypeptide Drug Sales by Type (2012-2017)
Table United States Polypeptide Drug Market Share by Type (2012-2017)
Table United States Polypeptide Drug Sales by Application (2012-2017)
Table United States Polypeptide Drug Market Share by Application (2012-2017)
Figure China Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure China Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure China Polypeptide Drug Sales Price Trend (2012-2017)
Table China Polypeptide Drug Sales by Manufacturers (2012-2017)
Table China Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table China Polypeptide Drug Sales by Type (2012-2017)
Table China Polypeptide Drug Market Share by Type (2012-2017)
Table China Polypeptide Drug Sales by Application (2012-2017)
Table China Polypeptide Drug Market Share by Application (2012-2017)
Figure Europe Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Europe Polypeptide Drug Sales Price Trend (2012-2017)
Table Europe Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Europe Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Europe Polypeptide Drug Sales by Type (2012-2017)
Table Europe Polypeptide Drug Market Share by Type (2012-2017)
Table Europe Polypeptide Drug Sales by Application (2012-2017)
Table Europe Polypeptide Drug Market Share by Application (2012-2017)
Figure Japan Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Japan Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Japan Polypeptide Drug Sales Price Trend (2012-2017)
Table Japan Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Japan Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Japan Polypeptide Drug Sales by Type (2012-2017)
Table Japan Polypeptide Drug Market Share by Type (2012-2017)
Table Japan Polypeptide Drug Sales by Application (2012-2017)
Table Japan Polypeptide Drug Market Share by Application (2012-2017)
Figure Southeast Asia Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Southeast Asia Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Polypeptide Drug Sales Price Trend (2012-2017)
Table Southeast Asia Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Southeast Asia Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Southeast Asia Polypeptide Drug Sales by Type (2012-2017)
Table Southeast Asia Polypeptide Drug Market Share by Type (2012-2017)
Table Southeast Asia Polypeptide Drug Sales by Application (2012-2017)
Table Southeast Asia Polypeptide Drug Market Share by Application (2012-2017)
Figure India Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure India Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure India Polypeptide Drug Sales Price Trend (2012-2017)
Table India Polypeptide Drug Sales by Manufacturers (2012-2017)
Table India Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table India Polypeptide Drug Sales by Type (2012-2017)
Table India Polypeptide Drug Market Share by Type (2012-2017)
Table India Polypeptide Drug Sales by Application (2012-2017)
Table India Polypeptide Drug Market Share by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Polypeptide Drug Global Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Serono Polypeptide Drug Global Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Polypeptide Drug Global Market Share (2012-2017)
Table Ipsen PHarma Biotech Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ipsen PHarma Biotech Polypeptide Drug Global Market Share (2012-2017)
Table Lilly Basic Information List
Table Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lilly Polypeptide Drug Global Market Share (2012-2017)
Table Asahi Kasei Basic Information List
Table Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Asahi Kasei Polypeptide Drug Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Polypeptide Drug Global Market Share (2012-2017)
Table SciClone Pharmaceuticals Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SciClone Pharmaceuticals Polypeptide Drug Global Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Polypeptide Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure Global Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Regions (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Type (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Application (2017-2022)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • キトサンの世界市場
    Chitosan Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, unit …
  • テレビ壁掛けの世界市場2016
    The Global TV Wall Mounts Industry 2016 Market Research Report is a professional and in-depth study on the current state of the TV Wall Mounts industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. Th …
  • 紙幣印刷機の世界市場2016
    The Global Banknote-Printing Machine Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Banknote-Printing Machine industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and indust …
  • 世界の整形外科用外傷治療デバイス市場2015
    The Global Orthopedic Trauma Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Orthopedic Trauma Devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain …
  • アプリケーションプロセッサの世界市場2015-2019
    About application processor An application processor is a SoC, designed to support applications running in an operating system environment such as Android, Apple iOS, Windows CE, or Symbian. As a battery occupies the maximum space in a mobile device, central processor unit, graphics processing unit, …
  • イタリアの女性不妊手術処置動向(~2020)
    Italy Female Sterilization Procedures Outlook to 2020 Summary GlobalData’s new report, "Italy Female Sterilization Procedures Outlook to 2020", provides key market data on the Italy Female Sterilization Procedures. The report provides procedure volumes for Transcervical Sterilization Procedures usin …
  • 皮膚潰瘍(Skin Ulcers):治療薬開発パイプライン動向2018
    SUMMARY DelveInsight’s, “ Skin Ulcers-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Skin Ulcers. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IN …
  • ITOガラスの世界市場2016
    Notes:Production, means the output of ITO Glass Revenue, means the sales value of ITO Glass This report studies ITO Glass in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, re …
  • ICT予算予測(中規模企業):スイス・ユーティリティー産業部門 – ICT予算内訳予測
    Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of su …
  • メキシコの個人衛生用品市場:消費者およびマーケットインサイト
    Summary The Anti-Perspirants and Deodorants category is the largest category accounting for 49.7% of the Personal Hygiene market in 2015 whereas the Soap category  is forecast to register the fastest growth  at a CAGR of 4.0% during 2015-2020. The Mexican government initiated many advertisements and …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR70301815 )"世界のポリペプチド薬市場2017" (英文:Global Polypeptide Drug Sales Market Report 2017)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。